KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Inventory Average (2016 - 2024)

Nektar Therapeutics (NKTR) has 14 years of Inventory Average data on record, last reported at $15.4 million in Q2 2024.

  • For Q2 2024, Inventory Average fell 24.98% year-over-year to $15.4 million; the TTM value through Jun 2024 reached $15.4 million, down 24.98%, while the annual FY2023 figure was $17.7 million, 0.86% up from the prior year.
  • Inventory Average reached $15.4 million in Q2 2024 per NKTR's latest filing, down from $16.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $20.5 million in Q2 2023 and bottomed at $12.7 million in Q3 2020.
  • Average Inventory Average over 5 years is $16.1 million, with a median of $15.7 million recorded in 2021.
  • Peak YoY movement for Inventory Average: rose 26.51% in 2023, then decreased 24.98% in 2024.
  • A 5-year view of Inventory Average shows it stood at $14.1 million in 2020, then grew by 10.46% to $15.6 million in 2021, then increased by 22.9% to $19.1 million in 2022, then decreased by 18.37% to $15.6 million in 2023, then dropped by 1.69% to $15.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $15.4 million in Q2 2024, $16.2 million in Q1 2024, and $15.6 million in Q4 2023.